These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 22490308)

  • 21. Influenza vaccine effectiveness in preventing hospitalizations with laboratory-confirmed influenza in Greece during the 2014-2015 season: A test-negative study.
    Lytras T; Kossyvakis A; Melidou A; Andreopoulou A; Exindari M; Gioula G; Kalliaropoulos A; Tryfinopoulou K; Pogka V; Spala G; Malisiovas N; Mentis A
    J Med Virol; 2016 Nov; 88(11):1896-904. PubMed ID: 27088266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interim influenza vaccine effectiveness: A good proxy for final estimates in Spain in the seasons 2010-2014.
    Jiménez-Jorge S; Pozo F; Larrauri A;
    Vaccine; 2015 Jun; 33(29):3276-80. PubMed ID: 25869892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.
    Skowronski DM; Masaro C; Kwindt TL; Mak A; Petric M; Li Y; Sebastian R; Chong M; Tam T; De Serres G
    Vaccine; 2007 Apr; 25(15):2842-51. PubMed ID: 17081662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants.
    Janjua NZ; Skowronski DM; De Serres G; Dickinson J; Crowcroft NS; Taylor M; Winter AL; Hottes TS; Fonseca K; Charest H; Drews SJ; Sabaiduc S; Bastien N; Li Y; Gardy JL; Petric M
    J Infect Dis; 2012 Jun; 205(12):1858-68. PubMed ID: 22492921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study.
    Kissling E; Valenciano M; Larrauri A; Oroszi B; Cohen JM; Nunes B; Pitigoi D; Rizzo C; Rebolledo J; Paradowska-Stankiewicz I; Jiménez-Jorge S; Horváth JK; Daviaud I; Guiomar R; Necula G; Bella A; O'Donnell J; Głuchowska M; Ciancio BC; Nicoll A; Moren A
    Euro Surveill; 2013 Jan; 18(5):. PubMed ID: 23399425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of the 2010/11 seasonal trivalent influenza vaccine in Spain: preliminary results of a case-control study.
    Savulescu C; Jiménez-Jorge S; de Mateo S; Ledesma J; Pozo F; Casas I; Larrauri A;
    Euro Surveill; 2011 Mar; 16(11):. PubMed ID: 21435330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using surveillance to evaluate influenza vaccine effectiveness.
    Jackson LA
    J Infect Dis; 2009 Jan; 199(2):155-8. PubMed ID: 19086916
    [No Abstract]   [Full Text] [Related]  

  • 28. Influenza vaccine effectiveness among 50-64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003-2004.
    Herrera GA; Iwane MK; Cortese M; Brown C; Gershman K; Shupe A; Averhoff F; Chaves SS; Gargiullo P; Bridges CB
    Vaccine; 2007 Jan; 25(1):154-60. PubMed ID: 17064823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimation of type- and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008.
    Fielding JE; Grant KA; Papadakis G; Kelly HA
    BMC Infect Dis; 2011 Jun; 11():170. PubMed ID: 21669006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using sentinel surveillance to monitor effectiveness of influenza vaccine is feasible: a pilot study in Denmark.
    Mazick A; Christiansen AH; Samuelsson S; Mølbak K
    Euro Surveill; 2006; 11(10):254-6. PubMed ID: 17130655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada's Sentinel Physician Surveillance Network, January 2015.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Dickinson JA; Winter AL; Drews SJ; Fonseca K; Charest H; Gubbay JB; Petric M; Krajden M; Kwindt TL; Martineau C; Eshaghi A; Bastien N; Li Y
    Euro Surveill; 2015 Jan; 20(4):. PubMed ID: 25655053
    [No Abstract]   [Full Text] [Related]  

  • 32. Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013-14: Results from the InNHOVE network.
    Rondy M; Castilla J; Launay O; Costanzo S; Ezpeleta C; Galtier F; de Gaetano Donati K; Moren A
    Hum Vaccin Immunother; 2016 May; 12(5):1217-24. PubMed ID: 27065000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of subunit influenza vaccination in the 2014-2015 season and residual effect of split vaccination in previous seasons.
    Castilla J; Navascués A; Fernández-Alonso M; Reina G; Pozo F; Casado I; Guevara M; Martínez-Baz I; Barricarte A; Ezpeleta C; ;
    Vaccine; 2016 Mar; 34(11):1350-7. PubMed ID: 26854911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influenza vaccine effectiveness against medically-attended influenza illness during the 2012-2013 season in Beijing, China.
    Yang P; Thompson MG; Ma C; Shi W; Wu S; Zhang D; Wang Q
    Vaccine; 2014 Sep; 32(41):5285-9. PubMed ID: 25092635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe.
    Kissling E; Rondy M;
    Euro Surveill; 2017 Feb; 22(7):. PubMed ID: 28230524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influenza vaccine effectiveness during the 2012 influenza season in Victoria, Australia: influences of waning immunity and vaccine match.
    Sullivan SG; Komadina N; Grant K; Jelley L; Papadakis G; Kelly H
    J Med Virol; 2014 Jun; 86(6):1017-25. PubMed ID: 24395730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18.
    Castilla J; Navascués A; Casado I; Pérez-García A; Aguinaga A; Ezpeleta G; Pozo F; Ezpeleta C; Martínez-Baz I; ;
    Euro Surveill; 2018 Feb; 23(7):. PubMed ID: 29471624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influenza vaccine effectiveness in the tropics: moderate protection in a case test-negative analysis of a hospital-based surveillance population in Bangkok between August 2009 and January 2013.
    Levy JW; Simasathien S; Watanaveeradej V; Bhoomiboonchoo P; Fernandez S; Jarman RG; Klungthong C; Gibbons RV; Kerdpanich P; Piboonbanakit D; Chirabandhu T; Yoon IK
    PLoS One; 2015; 10(8):e0134318. PubMed ID: 26267430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interim estimates of influenza vaccine effectiveness in 2012/13 from Canada's sentinel surveillance network, January 2013.
    Skowronski DM; Janjua NZ; De Serres G; Dickinson JA; Winter AL; Mahmud SM; Sabaiduc S; Gubbay JB; Charest H; Petric M; Fonseca K; Van Caeseele P; Kwindt TL; Krajden M; Eshaghi A; Li Y
    Euro Surveill; 2013 Jan; 18(5):. PubMed ID: 23399422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low vaccine effectiveness against influenza A(H3N2) virus among elderly people in Denmark in 2012/13--a rapid epidemiological and virological assessment.
    Bragstad K; Emborg H; Fischer TK; Voldstedlund M; Gubbels S; Andersen B; Molbak K; Krause T
    Euro Surveill; 2013 Feb; 18(6):. PubMed ID: 23410258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.